Cell culture metabolomics in the diagnosis of lung cancer—the influence of cell culture conditions
暂无分享,去创建一个
M. Myers | U. Kalluri | M. Naiker | U Kalluri | M Naiker | M A Myers | M. Naiker | Mark A. Myers
[1] Konrad Schwarz,et al. Compounds enhanced in a mass spectrometric profile of smokers' exhaled breath versus non-smokers as determined in a pilot study using PTR-MS , 2008, Journal of breath research.
[2] Anton Amann,et al. TD-GC-MS Analysis of Volatile Metabolites of Human Lung Cancer and Normal Cells In vitro , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[3] P. Španěl,et al. The challenge of breath analysis for clinical diagnosis and therapeutic monitoring. , 2007, The Analyst.
[4] Ulrike Tisch,et al. Volatile Organic Compounds in Exhaled Breath as Biomarkers for the Early Detection and Screening of Lung Cancer , 2012 .
[5] Kevin Gleeson,et al. Detection of lung cancer with volatile markers in the breath. , 2003, Chest.
[6] W. Miekisch,et al. Breath gas aldehydes as biomarkers of lung cancer , 2009, International journal of cancer.
[7] H. Issaq,et al. Promotion of mouse lung tumors by bioaccumulated polychlorinated aromatic hydrocarbons. , 1991, Experimental lung research.
[8] Tomas Mikoviny,et al. Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro , 2008, Cancer Cell International.
[9] Stephen S. Hecht,et al. Approaches to Cancer Prevention Based on an Understanding of N-Nitrosamine Carcinogenesis , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[10] Philip Hahnfeldt,et al. Cancer: looking outside the genome , 2000, Nature Reviews Molecular Cell Biology.
[11] X. Zhang,et al. Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[12] W. Miekisch,et al. Diagnostic potential of breath analysis--focus on volatile organic compounds. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[13] M. Takino,et al. Analysis of volatile sulphur compounds in breath by gas chromatography-mass spectrometry using a three-stage cryogenic trapping preconcentration system. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[14] C. Kneepkens,et al. The hydrocarbon breath test in the study of lipid peroxidation: principles and practice. , 1992, Clinical and investigative medicine. Medecine clinique et experimentale.
[15] M. Mehrali,et al. A review on powder-based additive manufacturing for tissue engineering: selective laser sintering and inkjet 3D printing , 2015, Science and technology of advanced materials.
[16] C. Mathers,et al. Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.
[17] J W Dallinga,et al. A profile of volatile organic compounds in breath discriminates COPD patients from controls. , 2009, Respiratory medicine.
[18] P. Boyle,et al. Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study. , 1994, European journal of clinical nutrition.
[19] Hossam Haick,et al. Volatile organic compounds of lung cancer and possible biochemical pathways. , 2012, Chemical reviews.
[20] C. Kneepkens,et al. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. , 1994, Free radical biology & medicine.
[21] A. Hauschild,et al. Integrated statistical learning of metabolic ion mobility spectrometry profiles for pulmonary disease identification. , 2012, Genetics and molecular research : GMR.
[22] G. Wilson. Hypoxia and prognosis: the oxygen tension mounts. , 2007, Frontiers in bioscience : a journal and virtual library.
[23] H. J. O’neill,et al. Volatile organic compounds in exhaled air from patients with lung cancer. , 1985, Clinical chemistry.
[24] V. Devita,et al. Cancer : Principles and Practice of Oncology , 1982 .
[25] T. Risby,et al. Current status of clinical breath analysis , 2005 .
[26] Kirsten Peters,et al. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines. , 2008, International journal of oncology.
[27] Wolfgang Losert,et al. Understanding health and disease with multidimensional single-cell methods , 2013, Journal of physics. Condensed matter : an Institute of Physics journal.
[28] T. Risby. Critical issues for breath analysis , 2008 .
[29] David Smith,et al. Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.
[30] Breath volatile analysis from patients diagnosed with harmful drinking, cirrhosis and hepatic encephalopathy: a pilot study , 2013, Metabolomics.
[31] Bradford G. Stone,et al. Effect of regulating cholesterol biosynthesis on breath isoprene excretion in men , 1993, Lipids.
[32] P. Vaupel,et al. Tumor hypoxia and malignant progression. , 2009, Methods in enzymology.
[33] Bogusław Buszewski,et al. Human exhaled air analytics: biomarkers of diseases. , 2007, Biomedical chromatography : BMC.
[34] T. Hintze,et al. Cytochrome P-450 oxidation of alkanes originating as scission products during lipid peroxidation. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.
[35] N. Denko,et al. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.
[36] S. Loft,et al. Cancer risk and oxidative DNA damage in man , 1996, Journal of Molecular Medicine.
[37] Adrian L. Harris,et al. Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.
[38] Tomas Mikoviny,et al. Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro. , 2009, Anticancer research.
[39] G. Semenza,et al. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.
[40] Wolfram Miekisch,et al. From highly sophisticated analytical techniques to life-saving diagnostics: Technical developments in breath analysis , 2006 .
[41] D. Crowther,et al. Cancer—Principles and Practice of Oncology. V , 1982, British Journal of Cancer.
[42] J. Pouysségur,et al. Oxygen, a source of life and stress , 2007, FEBS letters.
[43] A. B. Robinson,et al. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[44] M. Phillips,et al. Effect of age on the breath methylated alkane contour, a display of apparent new markers of oxidative stress. , 2000, The Journal of laboratory and clinical medicine.
[45] Sven Rahmann,et al. IMS2 - An integrated medical software system for early lung cancer detection using ion mobility spectrometry data of human breath , 2007, J. Integr. Bioinform..
[46] Robert G. Hahn,et al. Role of Variability in Explaining Ethanol Pharmacokinetics , 2003, Clinical pharmacokinetics.
[47] Anton Amann,et al. Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas , 2007 .
[48] M. Phillips,et al. Breath tests in medicine. , 1992, Scientific American.
[49] Anton Amann,et al. Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells. , 2011, Cancer biomarkers : section A of Disease markers.
[50] E. Wouters,et al. Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[51] T. H. Risby. CURRENT STATUS OF CLINICAL BREATH ANALYSIS , 2005 .
[52] M. Ledochowski, B. Widner, C. Murr, B. Sperner-Unt. Fructose Malabsorption is Associated with Decreased Plasma Tryptophan , 2001 .
[53] S. Loft,et al. Cancer risk and oxidative DNA damage in man , 1997, Journal of Molecular Medicine.
[54] D. Fuchs,et al. Fructose malabsorption is associated with decreased plasma tryptophan. , 2001, Scandinavian journal of gastroenterology.
[55] A. Jemal,et al. Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[56] Padma Maruvada,et al. Metabolomics in biomarker discovery: future uses for cancer prevention. , 2008, Future oncology.
[57] P. Okunieff,et al. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.
[58] Ping Wang,et al. Detection of Lung Cancer with Volatile Organic Biomarkers in Exhaled Breath and Lung Cancer Cells , 2009 .
[59] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[60] S. Batra,et al. Lipid peroxidation, free radical production and antioxidant status in breast cancer , 2004, Breast Cancer Research and Treatment.
[61] Minro Watanabe,et al. Polymorphic CYP genes and disease predisposition--what have the studies shown so far? , 1998, Toxicology letters.
[62] M. Phillips,et al. Variation in volatile organic compounds in the breath of normal humans. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[63] Solid phase microextraction for analysis of alkanes and aromatic hydrocarbons in human breath. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[64] Peter Vaupel,et al. Tumor microenvironmental physiology and its implications for radiation oncology. , 2004, Seminars in radiation oncology.
[65] Eko Supriyanto,et al. Tangible nanocomposites with diverse properties for heart valve application , 2015, Science and technology of advanced materials.
[66] Ping Wang,et al. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis , 2007, Cancer.
[67] G. Kalna,et al. Metabolic Profiling of Hypoxic Cells Revealed a Catabolic Signature Required for Cell Survival , 2011, PloS one.
[68] Yu. A. Zolotov. Breath Analysis , 2005 .
[69] N. Bellance,et al. Metabolomics for mitochondrial and cancer studies. , 2011, Biochimica et biophysica acta.
[70] R. Jain. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. , 2002, Seminars in oncology.
[71] R. Wenger,et al. Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[72] Kohji Mitsubayashi,et al. Bioelectronic sniffers for ethanol and acetaldehyde in breath air after drinking. , 2005, Biosensors & bioelectronics.
[73] J. Lindon,et al. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.
[74] L. Bianchi,et al. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study , 2005, Respiratory research.
[75] David Smith,et al. A longitudinal study of ethanol and acetaldehyde in the exhaled breath of healthy volunteers using selected-ion flow-tube mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.
[76] A. Hansel,et al. Acetonitrile and benzene in the breath of smokers and non-smokers investigated by proton transfer reaction mass spectrometry (PTR-MS) , 1995 .
[77] J. Lindon,et al. Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.